131 related articles for article (PubMed ID: 478636)
1. Rabies virus immunity in genetically selected high- and low-responder lines of mice.
Nilsson MR; Sant'anna OA; Siqueira M; Nilsson TT; Gennari M
Infect Immun; 1979 Jul; 25(1):23-6. PubMed ID: 478636
[TBL] [Abstract][Full Text] [Related]
2. Polygenic control of antibody production and correlation with vaccine induced resistance to rabies virus in high and low antibody responder mice.
De Franco M; Massa S; Vassão RC; Siqueira M; Sant'Anna OA
Arch Virol; 1996; 141(8):1397-406. PubMed ID: 8856022
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of different specific immunological parameters after rabies vaccination in mice.
Blancou J; Andral L; Lagrange PH; Tsiang H
Infect Immun; 1979 Jun; 24(3):600-5. PubMed ID: 468369
[TBL] [Abstract][Full Text] [Related]
4. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
[No Abstract] [Full Text] [Related]
5. Cell mediated immune response in canine antirabies vaccination.
Timenetsky J; Chamelet EL; Mendes NF; Pereira OA
Rev Inst Med Trop Sao Paulo; 1985; 27(1):1-5. PubMed ID: 4035202
[No Abstract] [Full Text] [Related]
6. Rabies antibody titres in vaccinated reindeer.
Sihvonen L; Kulonen K; Soveri T; Nieminen M
Acta Vet Scand; 1993; 34(2):199-202. PubMed ID: 8266898
[TBL] [Abstract][Full Text] [Related]
7. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice.
Lafon M; Bourhy H; Sureau P
Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007
[TBL] [Abstract][Full Text] [Related]
8. Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice.
Templeton JW; Holmberg C; Garber T; Sharp RM
J Virol; 1986 Jul; 59(1):98-102. PubMed ID: 3086569
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
[TBL] [Abstract][Full Text] [Related]
10. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF
Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222
[TBL] [Abstract][Full Text] [Related]
11. BCG modulation of delayed type hypersensitivity, humoral response and acquired resistance after rabies vaccination.
Tsiang H; Blancou J; Lagrange PH
Arch Virol; 1981; 69(3-4):167-76. PubMed ID: 7295038
[TBL] [Abstract][Full Text] [Related]
12. [Complement-fixing rabies antibodies in mice vaccinated and posteriorly challenged].
Oliveira LH; Andrade CM; Reis W
An Microbiol (Rio J); 1980; 25():135-47. PubMed ID: 6982627
[No Abstract] [Full Text] [Related]
13. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody.
Lodmell DL; Parnell MJ; Weyhrich JT; Ewalt LC
Vaccine; 2003 Sep; 21(25-26):3998-4002. PubMed ID: 12922136
[TBL] [Abstract][Full Text] [Related]
14. Role of systemic injection of rabies immunoglobulin in rabies vaccination.
Wu W; Liu S; Yu P; Tao X; Lu X; Yan J; Wang Q; Zhang Z; Zhu W
Arch Virol; 2017 Jun; 162(6):1701-1703. PubMed ID: 28188373
[TBL] [Abstract][Full Text] [Related]
15. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.
Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H
J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404
[TBL] [Abstract][Full Text] [Related]
16. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers.
Lodmell DL; Parnell MJ; Bailey JR; Ewalt LC; Hanlon CA
Vaccine; 2002 May; 20(17-18):2221-8. PubMed ID: 12009276
[TBL] [Abstract][Full Text] [Related]
17. A model in mice for the study of the early death phenomenon after vaccination and challenge with rabies virus.
Blancou J; Andral B; Andral L
J Gen Virol; 1980 Oct; 50(2):433-5. PubMed ID: 7463005
[TBL] [Abstract][Full Text] [Related]
18. Studies on Japanese-produced chick embryo cell culture rabies vaccines.
Arai YT; Ogata T; Oya A
Am J Trop Med Hyg; 1991 Feb; 44(2):131-4. PubMed ID: 2012255
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies.
Welch RJ; Anderson BL; Litwin CM
J Med Microbiol; 2009 Jun; 58(Pt 6):806-810. PubMed ID: 19429758
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination.
Li Y; Zhou M; Luo Z; Zhang Y; Cui M; Chen H; Fu ZF; Zhao L
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
